Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
City of Hope Medical Center
City of Hope Medical Center
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Wugen, Inc.
Ohio State University Comprehensive Cancer Center
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
The First Affiliated Hospital of Soochow University
Thomas Jefferson University
National Cancer Institute (NCI)
Celgene
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Daiichi Sankyo
Boehringer Ingelheim
H. Lee Moffitt Cancer Center and Research Institute
HUYABIO International, LLC.
Kyowa Kirin Co., Ltd.
City of Hope Medical Center
Wake Forest University Health Sciences
Stanford University
University of Nebraska
University of Nebraska
University of Nebraska
Emory University
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Goethe University
Atara Biotherapeutics
National Institutes of Health Clinical Center (CC)
Goethe University
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Northwestern University
Roswell Park Cancer Institute
Hebei Senlang Biotechnology Inc., Ltd.
Universität des Saarlandes
Fred Hutchinson Cancer Center
miRagen Therapeutics, Inc.
National Cancer Institute (NCI)
Mayo Clinic
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Mayo Clinic
Fred Hutchinson Cancer Center